Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Radiotherapy × Tumor-Agnostic × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 21 Thoracic 18 Head & Neck 17 Genitourinary 15 Gastrointestinal 14 Breast 14 Sarcoma 9 Gynecologic 6 Lymphoid 5 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Other 1 NET 1 Endocrine 1 Dermatologic 1

Conditions

Interventions

Specimen Handling 15 Biopsy 15 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Paclitaxel 5 trastuzumab deruxtecan 4 Taxes 4 Interviews as Topic 4 Focus Groups 4 ipatasertib 3 atezolizumab 3 X-Rays 3 Standard of Care 3 Irinotecan 3 Fulvestrant 3 Drug Therapy 3 Cyclophosphamide 3 Carboplatin 3 Capecitabine 3 130-nm albumin-bound paclitaxel 3 zolbetuximab 2 tislelizumab 2 sintilimab 2 palbociclib 2 olaparib 2 nilotinib 2 inavolisib 2 fludarabine 2 durvalumab 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01428895 2026-03-06

Femoral Bone Metastases

University Health Network, Toronto

Phase NA Active not recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡